The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

The Global Medical Blood Lancet Market is projected to reach USD 1,552.9 million by the end of 2024 and grow steadily towards an expected value of USD 3,682.8 million by 2033 with compound annual ...

After having massive success with off-brand weight-loss drugs, the millennial-focused telehealth company Hims & Hers (HIMS) ...

The Global Medical Blood Lancet Market is projected to reach USD 1,552.9 million by the end of 2024 and grow steadily towards an expected value of USD 3,682.8 million by 2033 with compound annual ...

Lifestyle changes and medicine for cardiovascular problems may help lower the risks of blood vessel damage and so keep ...

Hims & Hers Health (HIMS) stock rocketed higher today after the telehealth platform operator announced plans to introduce ...

The report detailed 12 questions that patients should discuss with their physician that can help protect the brain from ...

Inhaling nicotine vapour from E-cigarettes has been described by the NHS as “substantially less harmful than smoking.” But Dr ...

Tile-T20 is the first DBS collection cartridge designed specifically for use with patient-centric blood lancets. Tile-T20 collects four precise, volumetrically-controlled blood samples that meet ...

Hims users will be provided a blood lancet provided by home diagnostic testing company Tasso. The lancet is a single-use device that collects whole liquid blood samples and cleared for premarket ...